$INGN
Inogen Inc

2017 Q1 Form 10-Q Financial Statement

#000156459017009850 Filed on May 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q4 2016 Q1
Revenue $52.50M $50.90M $42.99M
YoY Change 22.12% 25.85% 27.37%
Cost Of Revenue $26.76M $26.20M $21.71M
YoY Change 23.24% 28.43% 22.45%
Gross Profit $25.74M $24.70M $21.28M
YoY Change 20.98% 23.27% 32.8%
Gross Profit Margin 49.04% 48.53% 49.5%
Selling, General & Admin $18.86M $17.30M $16.83M
YoY Change 12.06% 13.07% 33.16%
% of Gross Profit 73.28% 70.04% 79.11%
Research & Development $1.309M $1.200M $1.168M
YoY Change 12.07% 0.0% 35.34%
% of Gross Profit 5.08% 4.86% 5.49%
Depreciation & Amortization $3.204M $3.270M $3.448M
YoY Change -7.08% -7.63% 0.12%
% of Gross Profit 12.45% 13.24% 16.2%
Operating Expenses $20.17M $18.50M $18.00M
YoY Change 12.06% 11.45% 33.3%
Operating Profit $5.571M $6.200M $3.277M
YoY Change 70.0% 80.34% 30.14%
Interest Expense $100.0K $100.0K $3.000K
YoY Change 3233.33% -57.14%
% of Operating Profit 1.8% 1.61% 0.09%
Other Income/Expense, Net $308.0K -$400.0K $123.0K
YoY Change 150.41% 100.0% -223.0%
Pretax Income $5.879M $5.834M $3.400M
YoY Change 72.91% 75.88% 40.61%
Income Tax -$53.00K $574.0K $879.0K
% Of Pretax Income -0.9% 9.84% 25.85%
Net Earnings $5.932M $9.600M $2.521M
YoY Change 135.3% 148.83% 60.37%
Net Earnings / Revenue 11.3% 18.86% 5.86%
Basic Earnings Per Share $0.29 $0.13
Diluted Earnings Per Share $0.27 $0.25 $0.12
COMMON SHARES
Basic Shares Outstanding 20.49M 20.31M 19.83M
Diluted Shares Outstanding 21.58M 21.36M 20.84M

Balance Sheet

Concept 2017 Q1 2016 Q4 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $128.2M $113.9M $86.10M
YoY Change 48.9% 37.38% 40.92%
Cash & Equivalents $105.1M $92.85M $72.40M
Short-Term Investments $23.10M $21.03M $13.70M
Other Short-Term Assets $2.800M $2.100M $1.700M
YoY Change 64.71% 61.54% -74.63%
Inventory $14.00M $14.34M $10.30M
Prepaid Expenses
Receivables $30.90M $30.83M $23.70M
Other Receivables $600.0K $500.0K $2.200M
Total Short-Term Assets $176.5M $161.5M $124.0M
YoY Change 42.34% 40.63% 23.38%
LONG-TERM ASSETS
Property, Plant & Equipment $23.80M $25.20M $29.60M
YoY Change -19.59% -17.86% -8.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $27.10M $410.0K $14.60M
YoY Change 85.62% 322.68% -4.58%
Total Long-Term Assets $51.10M $52.55M $56.78M
YoY Change -10.01% 13.08% 18.3%
TOTAL ASSETS
Total Short-Term Assets $176.5M $161.5M $124.0M
Total Long-Term Assets $51.10M $52.55M $56.78M
Total Assets $227.6M $214.0M $180.8M
YoY Change 25.9% 32.69% 21.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.885M $5.738M $8.504M
YoY Change 4.48% -22.96% -40.11%
Accrued Expenses $6.700M $8.900M $3.000M
YoY Change 123.33% 67.92% -36.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $200.0K
YoY Change -100.0% -33.33%
Total Short-Term Liabilities $25.29M $22.85M $24.00M
YoY Change 5.37% 3.78% 7.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $263.0K $282.0K $6.200M
YoY Change -95.76% -16.32% 87.88%
Total Long-Term Liabilities $263.0K $282.0K $6.200M
YoY Change -95.76% -16.32% 2516.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.29M $22.85M $24.00M
Total Long-Term Liabilities $263.0K $282.0K $6.200M
Total Liabilities $34.85M $31.96M $30.20M
YoY Change 15.41% 17.09% 33.6%
SHAREHOLDERS EQUITY
Retained Earnings -$6.431M -$12.36M -$30.36M
YoY Change -78.82% -72.59%
Common Stock $199.2M $194.5M
YoY Change 8.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $192.8M $182.1M $150.6M
YoY Change
Total Liabilities & Shareholders Equity $227.6M $214.0M $168.4M
YoY Change 35.17% 32.69% 13.43%

Cashflow Statement

Concept 2017 Q1 2016 Q4 2016 Q1
OPERATING ACTIVITIES
Net Income $5.932M $9.600M $2.521M
YoY Change 135.3% 148.83% 60.37%
Depreciation, Depletion And Amortization $3.204M $3.270M $3.448M
YoY Change -7.08% -7.63% 0.12%
Cash From Operating Activities $13.21M $5.180M $4.780M
YoY Change 176.36% -58.76% -21.12%
INVESTING ACTIVITIES
Capital Expenditures $593.0K -$230.0K $714.0K
YoY Change -16.95% -42.5% 29.35%
Acquisitions
YoY Change
Other Investing Activities -$3.170M -$320.0K $1.660M
YoY Change -290.96% 357.14% -147.7%
Cash From Investing Activities -$3.770M -$550.0K $940.0K
YoY Change -501.06% 14.58% -123.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $77.00K
YoY Change -4.94%
Cash From Financing Activities 2.800M 2.290M 520.0K
YoY Change 438.46% -308.18% -76.89%
NET CHANGE
Cash From Operating Activities 13.21M 5.180M 4.780M
Cash From Investing Activities -3.770M -550.0K 940.0K
Cash From Financing Activities 2.800M 2.290M 520.0K
Net Change In Cash 12.24M 6.920M 6.240M
YoY Change 96.15% -36.98% 46.14%
FREE CASH FLOW
Cash From Operating Activities $13.21M $5.180M $4.780M
Capital Expenditures $593.0K -$230.0K $714.0K
Free Cash Flow $12.62M $5.410M $4.066M
YoY Change 210.3% -58.26% -26.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2239000
CY2017Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1848000
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2760000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
25289000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22845000
CY2017Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
2160000
CY2016Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
1792000
CY2016Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1688000
CY2017Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7142000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7042000
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
263000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
282000
CY2017Q1 us-gaap Liabilities
Liabilities
34854000
CY2016Q4 us-gaap Liabilities
Liabilities
31961000
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
20000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
20000
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
199160000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
194466000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6431000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12363000
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
26000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
192775000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
182088000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
227629000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
214049000
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20559077
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20389860
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20559077
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20389860
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
45966000
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
32811000
CY2017Q1 ingn Rental Revenue Net
RentalRevenueNet
6534000
CY2016Q1 ingn Rental Revenue Net
RentalRevenueNet
10178000
CY2017Q1 us-gaap Revenues
Revenues
52500000
CY2016Q1 us-gaap Revenues
Revenues
42989000
CY2017Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21913000
CY2016Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16507000
CY2017Q1 ingn Cost Of Rental
CostOfRental
4843000
CY2016Q1 ingn Cost Of Rental
CostOfRental
5203000
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
26756000
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
21710000
CY2017Q1 ingn Gross Profit Sales Revenue
GrossProfitSalesRevenue
24053000
CY2016Q1 ingn Gross Profit Sales Revenue
GrossProfitSalesRevenue
16304000
CY2017Q1 ingn Gross Profit Rental Revenue
GrossProfitRentalRevenue
1691000
CY2016Q1 ingn Gross Profit Rental Revenue
GrossProfitRentalRevenue
4975000
CY2017Q1 us-gaap Gross Profit
GrossProfit
25744000
CY2016Q1 us-gaap Gross Profit
GrossProfit
21279000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1309000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1168000
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10529000
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8965000
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8335000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7869000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
20173000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
18002000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5571000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3277000
CY2016Q1 us-gaap Interest Expense
InterestExpense
3000
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
101000
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
29000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
207000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
97000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
308000
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
123000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5879000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3400000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-53000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
879000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
5932000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
2521000
CY2017Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
54000
CY2016Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-92000
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
57000
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000
CY2016Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-92000
CY2017Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
64000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
61000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-81000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2440000
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19827669
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20840367
CY2016Q1 us-gaap Cost Of Services Depreciation
CostOfServicesDepreciation
2947000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
134018000
CY2016Q1 ingn Cumulative Effect Of Change In Accounting Principle
CumulativeEffectOfChangeInAccountingPrinciple
12226000
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1295000
CY2016Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
500000
CY2016Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
92000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
150571000
CY2017Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1891000
CY2017Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
581000
CY2017Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2222000
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3204000
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3448000
CY2017Q1 ingn Gain Loss On Write Off Of Rental Units And Other Fixed Assets
GainLossOnWriteOffOfRentalUnitsAndOtherFixedAssets
-325000
CY2016Q1 ingn Gain Loss On Write Off Of Rental Units And Other Fixed Assets
GainLossOnWriteOffOfRentalUnitsAndOtherFixedAssets
-306000
CY2017Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
37000
CY2017Q1 ingn Provision For Sales Returns And Doubtful Accounts
ProvisionForSalesReturnsAndDoubtfulAccounts
3181000
CY2016Q1 ingn Provision For Sales Returns And Doubtful Accounts
ProvisionForSalesReturnsAndDoubtfulAccounts
2907000
CY2017Q1 ingn Health Care Organization Patient Service Revenue Adjustments
HealthCareOrganizationPatientServiceRevenueAdjustments
1731000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4045000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4260000
CY2017Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2291000
CY2016Q1 ingn Health Care Organization Patient Service Revenue Adjustments
HealthCareOrganizationPatientServiceRevenueAdjustments
2644000
CY2017Q1 us-gaap Inventory Write Down
InventoryWriteDown
7000
CY2016Q1 us-gaap Inventory Write Down
InventoryWriteDown
17000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1891000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1295000
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-54000
CY2016Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
834000
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5015000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9486000
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-49000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2170000
CY2017Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-16000
CY2016Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
123000
CY2017Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
129000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
773000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
315000
CY2016Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2254000
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
10100000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
593000
CY2017Q1 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
528000
CY2016Q1 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
456000
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
621000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
458000
CY2016Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-5000
CY2017Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-19000
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-16000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
13212000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4777000
CY2017Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
9988000
CY2016Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
6990000
CY2017Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
7950000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
714000
CY2017Q1 ingn Payments To Produce And Purchase Rental Equipment
PaymentsToProduceAndPurchaseRentalEquipment
1188000
CY2016Q1 ingn Payments To Produce And Purchase Rental Equipment
PaymentsToProduceAndPurchaseRentalEquipment
1455000
CY2017Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
54000
CY2016Q1 ingn Reimbursement Of Deposit
ReimbursementOfDeposit
1000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3765000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
942000
CY2017Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2222000
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
92000
CY2017Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
581000
CY2016Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
500000
CY2016Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
77000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2803000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
515000
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
4000
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
60000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12254000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6294000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66106000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72400000
CY2016Q1 us-gaap Interest Paid
InterestPaid
4000
CY2017Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
45000
CY2016Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5000
CY2017Q1 ingn Patients Using Portable Oxygen Concentrators
PatientsUsingPortableOxygenConcentrators
0.08
CY2017Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&nbsp;&nbsp;Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements and other factors that management believes to be reasonable. Significant areas requiring the use of management estimates relate to revenue recognition, inventory and rental asset valuations and write-downs, accounts receivable allowances for bad debts, returns and adjustments, stock compensation expense, depreciation and amortization, income tax provision and uncertain tax positions, and fair value of financial instruments. Actual results could differ from these estimates.</p></div>
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
23135000
CY2017Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
51200000
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
48533000
CY2017Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
1718000
CY2016Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
5041000
CY2017Q1 ingn Corporate Bonds At Carrying Value
CorporateBondsAtCarryingValue
6025000
CY2017Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
6363000
CY2016Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
7484000
CY2017Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
38493000
CY2016Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
39360000
CY2017Q1 ingn Doubtful Accounts
DoubtfulAccounts
1824000
CY2016Q4 ingn Doubtful Accounts
DoubtfulAccounts
1869000
CY2017Q1 ingn Rental Revenue Adjustments
RentalRevenueAdjustments
4628000
CY2016Q4 ingn Rental Revenue Adjustments
RentalRevenueAdjustments
6078000
CY2017Q1 ingn Allowances For Sales Returns
AllowancesForSalesReturns
1114000
CY2016Q4 ingn Allowances For Sales Returns
AllowancesForSalesReturns
585000
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7566000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8532000
CY2017Q1 ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.722
CY2016Q1 ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.683
CY2017Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
309000
CY2016Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
314000
CY2017Q1 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
11072000
CY2016Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
12382000
CY2017Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3102000
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2152000
CY2017Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
213000
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
191000
CY2017Q1 us-gaap Property Plant And Equipment Salvage Value
PropertyPlantAndEquipmentSalvageValue
0
CY2017Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
651000
CY2016Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
687000
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3177000
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3425000
CY2017Q1 ingn Rental Equipment Allowance
RentalEquipmentAllowance
617000
CY2016Q4 ingn Rental Equipment Allowance
RentalEquipmentAllowance
725000
CY2017Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2016Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23000
CY2017Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1345000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1345000
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1131000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1104000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
75000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
86000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
33000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
6000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8885000
CY2017Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2016Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2355527
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
157412
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
53465
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
33
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2144617
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
987534
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2063240
CY2017Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Per Share Price Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerSharePriceExpired
8.70
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
28.22
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5738000
CY2017Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
5137000
CY2016Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4290000
CY2017Q1 ingn Accrued Purchasing Card Liability
AccruedPurchasingCardLiability
1762000
CY2016Q4 ingn Accrued Purchasing Card Liability
AccruedPurchasingCardLiability
1760000
CY2017Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
334000
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
281000
CY2017Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
731000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
726000
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1090189
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1012698
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25700
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
773033
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
13.80
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
45.63
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.70
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
28.85
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
18.30
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
28.57
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M1D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M4D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y11M5D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y3M
CY2016 ingn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare
38.95
CY2017Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare
48.71
CY2017Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Exercisable Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExercisablePerShareAverageIntrinsicValue
59.26
CY2017Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Expected To Vest Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExpectedToVestPerShareAverageIntrinsicValue
48.99
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
13511000
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
10704000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
871000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1157000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1155000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
755000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
249000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
21000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4208000
CY2017Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
262000
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
264000
CY2017Q1 us-gaap Purchase Obligation
PurchaseObligation
47700000
CY2016Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3480000
CY2015Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1973000
CY2017Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1071000
CY2016 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3123000
CY2016 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
118000
CY2017Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
543000
CY2016 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1734000
CY2017Q1 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
12
CY2016Q1 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
20
CY2017Q1 ingn Number Of Contract Non Designated Hedges
NumberOfContractNonDesignatedHedges
3

Files In Submission

Name View Source Status
0001564590-17-009850-index-headers.html Edgar Link pending
0001564590-17-009850-index.html Edgar Link pending
0001564590-17-009850.txt Edgar Link pending
0001564590-17-009850-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ingn-10q_20170331.htm Edgar Link pending
ingn-20170331.xml Edgar Link completed
ingn-20170331.xsd Edgar Link pending
ingn-20170331_cal.xml Edgar Link unprocessable
ingn-20170331_def.xml Edgar Link unprocessable
ingn-20170331_lab.xml Edgar Link unprocessable
ingn-20170331_pre.xml Edgar Link unprocessable
ingn-ex101_614.htm Edgar Link pending
ingn-ex102_700.htm Edgar Link pending
ingn-ex311_7.htm Edgar Link pending
ingn-ex312_9.htm Edgar Link pending
ingn-ex321_8.htm Edgar Link pending
ingn-ex322_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending